Ad
related to: dr reddy's laboratories locations
Search results
Results From The WOW.Com Content Network
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy , who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited . [ 2 ]
Real estate in Bachupally is one of the major sector in the area contributing to the economy. [3] It is also referred to as the pharmaceutical hub of Hyderabad, as it houses R&D centers of top pharma manufacturers including Dr. Reddy's lab, Aurobindo Pharma, and SMS Pharma.
The National Institute of Virology in Pune, India is an Indian virology research institute and part of the Indian Council of Medical Research (ICMR). [2] It was previously known as 'Virus Research Centre' and was founded in collaboration with the Rockefeller Foundation.
Small-caps and large-caps are wildly popular among investors; however, mid-cap stocks, such as Dr. Reddy's Laboratories Limited (NSE:DRREDDY) with a market-capitalization of ₹432b, rarely draw ...
National Institute for Research in Bacterial Infections or NIRBI (also known as ICMR-NIRBI) previously known as National Institute of Cholera and Enteric Diseases [1] is an Indian medical institute that conducts research and develops prevention and treatment and control strategies related to enteric diseases and HIV/AIDS.
Divi's Laboratories [3] Dr. Reddy's Laboratories [4] Electronics Corporation of India; ETV Network; Glenmark Pharmaceuticals; GMR Group; GVK [5] Heritage Foods [6] Hetero Drugs; Indian Drugs and Pharmaceuticals (IDPL) Indian Immunologicals Limited [7] Krishna Institute of Medical Sciences; Laurus Labs; Satyam Computer Services Ltd [8] Skyroot ...
Two Indian chemical companies have been indicted for allegedly importing ingredients for the highly addictive opioid fentanyl into the United States and Mexico, the U.S. Department of Justice said ...
On 19 May 2021, Dr Reddy's Labs received Emergency Use Authorisation for anti-COVID drug 2-DG. [13] On 21 February 2022, Drugs Controller General of India granted approval to Biological E's COVID-19 vaccine Corbevax, that can be used for children between 12 and 18 years of age.